First NeuroLF System sold in Italy
The First NeuroLF system Sold in Italy
University Hospital of Genoa, Ospedale Policlinico San Martino, to become first NeuroLF center in Italy
Positrigo, a Swiss-based company developing advanced nuclear medicine devices to enhance functional brain imaging, today announced the first sale in Italy of its NeuroLF® dedicated brain PET system. The system will be installed at the University Hospital of Genoa, Ospedale Policlinico San Martino, marking Italy as the second European country to adopt the NeuroLF technology.
This milestone represents a significant step in Positrigo’s continued European expansion and underscores its mission to improve the accessibility and precision of neuroimaging worldwide. With this installation, Ospedale Policlinico San Martino will become the first NeuroLF center in Italy.
The sale and installation have been facilitated through Positrigo’s Italian distribution partner, Radius. Radius’s strong market presence and commitment to innovation have played a key role in introducing NeuroLF to leading Italian clinical and research institutions. Positrigo extends its sincere appreciation to Radius for their collaboration and support.
Prof. Gianmario Sambuceti, a leading expert in nuclear medicine and Scientific Head of the PET Center at the University Hospital of Genoa, commented on the upcoming installation:
“We are delighted to soon have access to the NeuroLF dedicated brain PET system. Its innovative design opens new possibilities for both research and clinical practice, particularly in the early detection and monitoring of neurodegenerative diseases. We look forward to integrating this technology into our work and advancing brain imaging in Italy.”
“We look forward to integrating the NeuroLF system into our work and advancing brain imaging in Italy – its innovative design opens new possibilities for both research and clinical practice.”
Prof. Gianmario Sambuceti, Scientific Head of the PET Center at the University Hospital of Genoa
NeuroLF is Positrigo’s next-generation, ultra-compact PET system designed exclusively for brain imaging. The system delivers high-quality functional imaging with a significantly reduced footprint, enabling new clinical applications and improved patient access while supporting advanced neurological research.
“We are proud to see NeuroLF adopted by such a prestigious institution,” states Dr. Jannis Fischer, CEO and Co-Founder of Positrigo. “This sale is not only an important commercial achievement, but also a testament to our shared commitment to advancing neurological diagnostics. We are grateful to Radius and to Prof. Sambuceti and his team for their trust in our technology.”
Mauro Mei, CEO of Radius, ads: “We are very pleased and proud to receive our first order in Italy from Ospedale Policlinico San Martino in Genoa. The hospital’s Nuclear Medicine Department, led by Prof. Sambuceti, is an outstanding national and international reference. Positrigo fits seamlessly into our Nuclear Medicine Business Unit and, together with our radiotherapy and pre-clinical offerings, reflects our strong focus on innovation and scientific excellence.”
Installation of the NeuroLF system at the University Hospital of Genoa is scheduled for the coming months, with clinical and research use expected to begin shortly thereafter.